Dr. Emily Curran, MD
Claim this profileUniversity of Cincinnati Cancer Center-UC Medical Center
Area of expertise
Acute Myeloid Leukemia
Emily Curran, MD has run 6 trials for Acute Myeloid Leukemia. Some of their research focus areas include:
Acute Myelogenous Leukemia
Emily Curran, MD has run 4 trials for Acute Myelogenous Leukemia. Some of their research focus areas include:
Affiliated Hospitals
University Of Cincinnati Cancer Center-UC Medical Center
University Of Cincinnati Cancer Center-West Chester
Clinical Trials Emily Curran, MD is currently running
Blinatumomab + Chemotherapy
for Leukemia
This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus blinatumomab. Blinatumomab is a Bi-specific T-Cell Engager ('BiTE') that may interfere with the ability of cancer cells to grow and spread. The information gained from this study may help researchers determine if combination therapy with steroids, TKIs, and blinatumomab work better than the standard of care.
Recruiting
2 awards
Phase 3
10 criteria
DFP-10917
for Acute Myeloid Leukemia
Phase III, multicenter, randomized study with two arms (1:1 ratio) enrolling patients with AML relapsed/refractory after 2, 3, or 4 prior induction regimens: Experimental arm: DFP-10917 14-day continuous intravenous (IV) infusion at a dose of 6 mg/m²/day followed by a 14-day resting period per 28-day cycles. Control arm: Non-Intensive Reinduction (LoDAC, Azacitidine, Decitabine, Venetoclax Combination Regimens) or Intensive Reinduction (High and Intermediate Dose Cytarabine Regimens), depending on the patient's prior induction treatment.
Recruiting
2 awards
Phase 3
4 criteria
More about Emily Curran, MD
Clinical Trial Related
5 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Emily Curran, MD has experience with
- Cytarabine
- Gilteritinib
- Daunorubicin
- Venetoclax
- SNDX-5613
- Rituximab
Breakdown of trials Emily Curran, MD has run
Acute Myeloid Leukemia
Acute Myelogenous Leukemia
Myelodysplastic Syndrome
Chronic Illness
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Emily Curran, MD specialize in?
Emily Curran, MD focuses on Acute Myeloid Leukemia and Acute Myelogenous Leukemia. In particular, much of their work with Acute Myeloid Leukemia has involved TP53 positive patients, or patients who are t(8;21) negative.
Is Emily Curran, MD currently recruiting for clinical trials?
Yes, Emily Curran, MD is currently recruiting for 5 clinical trials in Cincinnati Ohio. If you're interested in participating, you should apply.
Are there any treatments that Emily Curran, MD has studied deeply?
Yes, Emily Curran, MD has studied treatments such as Cytarabine, Gilteritinib, Daunorubicin.
What is the best way to schedule an appointment with Emily Curran, MD?
Apply for one of the trials that Emily Curran, MD is conducting.
What is the office address of Emily Curran, MD?
The office of Emily Curran, MD is located at: University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio 45219 United States. This is the address for their practice at the University of Cincinnati Cancer Center-UC Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.